These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Potentiation and inhibition of the amphetamine stereotypy in rats by neuroleptics and other agents. Lal S, Sourkes TL. Arch Int Pharmacodyn Ther; 1972 Oct; 199(2):289-301. PubMed ID: 4672248 [No Abstract] [Full Text] [Related]
6. The relationship between the lipophilic nature of tricyclic neuroleptics and antidepressants, and histamine release. Frisk-Holmberg M, van der Kleijn E. Eur J Pharmacol; 1972 May; 18(2):139-47. PubMed ID: 4113999 [No Abstract] [Full Text] [Related]
7. The prediction of sedative potency of neuroleptics. Loew DM. Mod Probl Pharmacopsychiatry; 1970 May; 5():47-50. PubMed ID: 5527167 [No Abstract] [Full Text] [Related]
8. Pharmacological properties of a new potential neuroleptic drug oxyprothepin. II. Influence on behaviour in rats. Kazdová E, Metysová J, Dlabac A. Act Nerv Super (Praha); 1971 May; 13(3):186-7. PubMed ID: 5113831 [No Abstract] [Full Text] [Related]
9. Pharmacological vs. clinical physiognomy of neuroleptics, with special reference to their sedative and antipsychotic effects. Nielsen IM. Acta Psychiatr Belg; 1974 Sep; 74(5):473-84. PubMed ID: 4471027 [No Abstract] [Full Text] [Related]
10. [Psychopharmacological studies of a new tranquilizer, thiothixene (Navane)]. Ueki S, Ogawa N, Kamata O, Gomita Y, Araki Y. Igaku Kenkyu; 1969 Nov; 39(5):434-53. PubMed ID: 5393785 [No Abstract] [Full Text] [Related]
11. Centrally active drugs and the medullary vasopressor response of the cat; a method of distinguishing between drug actions on the central and peripheral parts of the sympathetic nervous system. Elliott RC. Int J Neuropharmacol; 1969 Mar; 8(2):117-29. PubMed ID: 5783001 [No Abstract] [Full Text] [Related]
12. [Activity of various neuroleptics after single repeated treatment in the mice submitted to the four plate test and the escape test]. Gouret C, Raynaud G. C R Seances Soc Biol Fil; 1974 Mar; 168(2-3):270-5. PubMed ID: 4156656 [No Abstract] [Full Text] [Related]
13. [Phenamine antagonism as a treat for experimental evaluation of neuroleptics]. Raevskiĭ KS. Farmakol Toksikol; 1973 Mar; 36(2):149-54. PubMed ID: 4151668 [No Abstract] [Full Text] [Related]
14. PHENOTHIAZINE DERIVATIVES ON AVOIDANCE BEHAVIOR IN RATS. TANEMURA I, ITO S. Tohoku J Exp Med; 1965 Feb 25; 85():83-8. PubMed ID: 14285070 [No Abstract] [Full Text] [Related]
15. A battery of tests used for the evaluation of minor tranquillizers. Daleva L, Nikolova M, Stefanova D. Act Nerv Super (Praha); 1972 Feb 25; 14(1):46-9. PubMed ID: 5022652 [No Abstract] [Full Text] [Related]
16. [Neuroleptic therapy of schizophrenia from pharmacological viewpoint]. Stille G. Schweiz Med Wochenschr; 1969 Nov 15; 99(46):1645-52 contd. PubMed ID: 4391348 [No Abstract] [Full Text] [Related]
17. [The effect of some neuroleptics on the activity of acetylocholinesterase in the rat brain]. Borzecki Z. Ann Univ Mariae Curie Sklodowska Med; 1966 Nov 15; 21():363-5. PubMed ID: 5999706 [No Abstract] [Full Text] [Related]
18. [Behavioral and neuopharmacological effects of flupentixol]. Ueki S, Ogawa N, Watanabe S, Gomita Y, Araki Y. Igaku Kenkyu; 1971 Jul 15; 41(5):404-40. PubMed ID: 5165980 [No Abstract] [Full Text] [Related]